Bluefin Capital Management, LLC Amgen Inc Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.21 Million - $1.33 Million	-5,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.09 Million - $1.25 Million	5,500 New	5,500 $1.24 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $786,449 - $916,478	-3,544 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $766,850 - $913,182	3,544 New	3,544 $815,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.